Mission Therapeutics Begins Phase 1b Study of Experimental Parkinson’s Treatment
The international study will examine whether MTX325 affects processes linked to Parkinson’s disease, as well as assess its safety and tolerability. As reported in a recent press release, Mission Therapeutics says…